5/6/2013

The FDA has granted Merck & Co. approval for its Liptruzet drug to reduce LDL cholesterol levels. The drug is a combination of Merck's Zetia pill and a generic copy of Lipitor, made by Pfizer.

Full Story:
Bloomberg

Related Summaries